UK markets closed

Lonza Group Ltd (0QNO.IL)

IOB - IOB Delayed price. Currency in CHF
Add to watchlist
402.200.00 (0.00%)
At close: 03:51PM GMT
Full screen
Previous close402.20
Bid0.00 x N/A
Ask0.00 x N/A
Day's range396.40 - 404.10
52-week range396.40 - 767.40
Avg. volume0
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Vertex and Lonza to Build Dedicated Manufacturing Facility for Type 1 Diabetes (T1D) Cell Therapies

    BOSTON & BASEL, Switzerland, June 26, 2023--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Lonza (SIX: LONN) today announced a strategic collaboration to support the manufacture of Vertex’s portfolio of investigational stem cell-derived, fully differentiated insulin-producing islet cell therapies for people with T1D, currently focusing on the VX-880 and VX-264 programs that are currently in clinical trials.

  • Globe Newswire

    Simris Alg ab Signs Partnership Agreement With Lonza Ltd to Promote Its Adc Payload Technology

    Strategic collaboration agreement to commercialize Simris’ novel Antibody-Drug Conjugate (ADC) payload platformSimris grants Lonza, as its Contract Development & Manufacturing Organization (CDMO) partner, the global exclusive rights to offer its ADC technology to biopharmaceutical companiesSimris will promote Lonza as its exclusive CDMO partner to customers interested in licensing its technology Stockholm, Sweden, March 06, 2023 (GLOBE NEWSWIRE) -- Simris Alg AB (publ), a European biologics comp